KRAS and lung carcinoma: In the specific context of KRAS mutant lung cancer, aberrant KRAS signaling drives metabolic rewiring, promoting aerobic glycolysis (the Warburg effect), glutamine addiction, and altered lipid metabolism to fuel tumor progression.